155 related articles for article (PubMed ID: 15848587)
1. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
Buell JF; Gross TG; Hanaway MJ; Trofe J; Roy-Chaudhury P; First MR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):954-5. PubMed ID: 15848587
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.
Buell JF; Gross TG; Hanaway MJ; Trofe J; Muthiak C; First MR; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):956-7. PubMed ID: 15848588
[TBL] [Abstract][Full Text] [Related]
3. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
[TBL] [Abstract][Full Text] [Related]
5. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
Birkeland SA; Hamilton-Dutoit S; Bendtzen K
Transplantation; 2003 Jul; 76(1):153-8. PubMed ID: 12865802
[TBL] [Abstract][Full Text] [Related]
7. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
Raj R; Frost AE
J Heart Lung Transplant; 2005 Jun; 24(6):671-9. PubMed ID: 15949726
[TBL] [Abstract][Full Text] [Related]
8. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
9. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
Aull MJ; Buell JF; Trofe J; First MR; Alloway RR; Hanaway MJ; Wagoner L; Gross TG; Beebe T; Woodle ES
Transplantation; 2004 Dec; 78(11):1676-82. PubMed ID: 15591959
[TBL] [Abstract][Full Text] [Related]
10. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant lymphoproliferative disease: a series of 23 cases.
Martín-Gómez MA; Peña M; Cabello M; Burgos D; Gutierrez C; Sola E; Acedo C; Bailén A; Gonzalez-Molina M
Transplant Proc; 2006 Oct; 38(8):2448-50. PubMed ID: 17097963
[TBL] [Abstract][Full Text] [Related]
12. Sinonasal posttransplant lymphoproliferative disorder in pediatric lung transplant patients.
Herrmann BW; Sweet SC; Molter DW
Otolaryngol Head Neck Surg; 2005 Jul; 133(1):38-41. PubMed ID: 16025050
[TBL] [Abstract][Full Text] [Related]
13. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
15. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
[TBL] [Abstract][Full Text] [Related]
16. Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.
Herrmann BW; Sweet SC; Hayashi RJ; Canter CE; White FV; Lieu JE
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):303-10. PubMed ID: 16125255
[TBL] [Abstract][Full Text] [Related]
17. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
Saadat A; Einollahi B; Ahmadzad-Asl MA; Moradi M; Nafar M; Pourfarziani V; Firoozan A; Porrezagholi F; Davoudi F
Transplant Proc; 2007 May; 39(4):1071-3. PubMed ID: 17524894
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.
Buell JF; Gross T; Alloway RR; Trofe J; Woodle ES
Transplant Proc; 2005 Mar; 37(2):583-4. PubMed ID: 15848464
[TBL] [Abstract][Full Text] [Related]
19. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
Gheorghe G; Radu O; Milanovich S; Hamilton RL; Jaffe R; Southern JF; Ozolek JA
Pediatr Dev Pathol; 2013; 16(2):67-73. PubMed ID: 23286282
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-pathological analysis of 6 cases of post-transplant lymphoproliferative disorders].
Wang ZM; Zheng SS; Ding W; Wang LJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):514-8. PubMed ID: 18078125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
